WHWK
Whitehawk Therapeutics
$3.46
+$0.13 (+3.9%)Oct 28, 2026
Key metrics
The numbers that frame WHWK today
- Market cap
- $197.25M
- ROIC
- -80.4%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.97
- 52wk High
- $5.50
Growth
Revenue and earnings trend for WHWK
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about WHWK
Is Whitehawk Therapeutics a good buy?
Hold. Whitehawk Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Whitehawk Therapeutics is selling at a very high price.
What is the market capitalization of WHWK?
Whitehawk Therapeutics's market capitalization is $197.25M.
What is the 52-week high for WHWK stock?
The 52-week high for Whitehawk Therapeutics is $5.50. The current close of $3.46 is 37% below that high.
What is the 52-week low for WHWK stock?
The 52-week low for Whitehawk Therapeutics is $1.97. The current close of $3.46 is 75.6% above that low.
Does WHWK stock pay dividends?
Whitehawk Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for WHWK?
Whitehawk Therapeutics's Debt / Equity ratio is 0.